Efficacy and safety of ibrutinib in central nervous system lymphoma: A systematic review and meta-analysis

Efficacy and safety of ibrutinib in central nervous system lymphoma: A systematic review and meta-analysis

<h3>Background</h3><p dir="ltr"><u>Primary central nervous system lymphoma</u> (CNSL) is a rare, aggressive non-Hodgkin lymphoma confined to the CNS. Although radiation and chemotherapy, particularly high-dose <u>methotrexate</u> (HD-MTX), are effe...

Full description

Saved in:
Bibliographic Details
Main Author: Jaber H. Jaradat (21632849) (author)
Other Authors: Ibraheem M. Alkhawaldeh (17430888) (author), Yousef Al-Bojoq (22282816) (author), Monther N. Ramadan (22282819) (author), Mohammad T. Abuawwad (17632242) (author), Yasmeen Jamal Alabdallat (19920491) (author), Abdulqadir J. Nashwan (11659453) (author)
Published: 2024
Subjects:
Biomedical and clinical sciences
Cardiovascular medicine and haematology
Immunology
Oncology and carcinogenesis
Pharmacology and pharmaceutical sciences
Ibrutinib
BTK
Bruton tyrosine kinase inhibitor
CNSL
Central nervous system lymphoma
Lymphoma
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items